STOCK TITAN
  1. Home
  2. News
  3. BWVI

BLUE WATER VENTURES INC - BWVI STOCK NEWS

Welcome to our dedicated news page for BLUE WATER VENTURES (Ticker: BWVI), a resource for investors and traders seeking the latest updates and insights on BLUE WATER VENTURES.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BLUE WATER VENTURES's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BLUE WATER VENTURES's position in the market.

News
Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space
Rhea-AI Summary
Psycheceutical Bioscience, Inc. (BWVI) faced challenges in the psychedelic space due to regulatory filing deficiencies from over a decade ago. The company appointed Neilank K. Jha, MD, as Executive Chairman and CEO to initiate a turnaround for operational, financial, and regulatory reasons. Dr. Jha led an organizational transformation involving substantial operational and financial changes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.69%
Tags
none
-
News
Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc.
Rhea-AI Summary
Psycheceutical Bioscience, Inc. (OTC PINK:BWVI) appoints Dr. Neilank K. Jha as the new Executive Chairman and CEO, transitioning Chad Harman to COO and President of its subsidiary. Dr. Jha's extensive medical and business background will drive the company's focus on pioneering advancements in neuroscience and Brain-Computer Interface (BCI) technologies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
none
-
News
Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing
Rhea-AI Summary
Psycheceutical Bioscience, Inc. has launched a community crowdfunding campaign on Wefunder to support its mission of revolutionizing mental health treatment. The company's NeuroDirect ketamine technology, the first ketamine topical for treating PTSD, has shown positive results in clinical trials. Kevin Harrington, an 'Original Shark' from Shark Tank, has joined as an investor and strategic advisor. Psycheceutical is developing patented delivery technologies to increase the safety and efficacy of psychedelic compounds.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.86%
Tags
none
News
Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
clinical trial
-
News
Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy
Rhea-AI Summary
Psycheceutical Bioscience, Inc. (OTC PINK:BWVI) completes multi-year PCAOB audited financials, sets future corporate action for name and symbol change, and announces progress in drug development strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.82%
Tags
none
-
News
First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.83%
Tags
clinical trial
News
Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
none
-
News
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
none
News
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.88%
Tags
clinical trial
Stock BWVI logo
BLUE WATER VENTURES INC

OTC:BWVI

BWVI Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

BWVI Stock Data

5.39M
Specialty Business Services
Industrials
Link
United States of America
Green Cove Springs

About BWVI

blue water ventures international mission is to locate and recover historic sunken ships whose cargos offer material, intellectual, and social rewards. with the commitment to responsible and cooperative exploration of our shared marine environment through industry best practices and standards, open dissemination of knowledge, transparency of intent, and international cooperation. this is where you will find news about our projects and information and links on everything from historic shipwreck recovery and researching shipwrecks to how we the finance the expeditions, locating, recovering, and preserving what is found, the tools, the techniques, the adventure of the hunt, and the thrill of the find.